Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast Cancer
Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
This is a nonrandomized study of pemetrexed plus carboplatin, with the primary objective of
determining the efficacy of the combination in tumor reduction, in patients with locally
advanced or metastatic breast cancer.